AcuityMD Earns Spot on Forbes’ Billion-Dollar Startups List

AcuityMD is en route to a bright future.

The 6-year-old medtech intelligence platform developer is likely to become a billion-dollar company in time, thanks to its prowess in matching companies with customers. Last week, the firm was named to Forbes’ 2025 “Next Billion-Dollar Startups” list—a group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. The list, according to the magazine, has a strong track record: more than 100 startups named in the past 10 years have since become unicorns.

The recognition highlights AcuityMD’s rapid growth and innovation since its inception in 2019. Over the past year, the company signed its 300th customer, launched two innovative products, and doubled its staff, including the addition of Brian Collins as chief product officer. Collins has decades of product leadership experience from Salesforce, Demandware, Oracle, and other category-defining companies.

AcuityMD is the first entry on the list. Forbes provides a brief overview of the firm and its potential for growth, stating, “If you want to build medical devices, you need patients. Boston-based AcuityMD helps manufacturers find the right physicians based on the patients they treat by using de-identified data (think surgical histories, medical referrals) for 325 million people to craft marketing plans. Customers include Synchron, which used it to find patients for a brain-computer interface preclinical trial, and Intellijoint, which did so to market a new surgical tool for hip and knee replacements.”

While it is off to a strong start, AcuityMD has a ways to go before it joins the billionaire business club. Following a $45 million Series B funding round in 2024, AcuityMD’s total funding currently exceeds $83 million. As the global medical devices market is expected to expand from about $542 billion in 2024 to $886 billion by 2032, AcuityMD is well-positioned to capitalize on this growth trajectory, according to the company.

“Being named on the Forbes list is a testament to our team’s dedication to customers and commitment to our mission: to accelerate the adoption of cutting-edge medical technologies,” AcuityMD Co-Founder/CEO Mike Monovoukas stated. “While we are grateful to be recognized, we remain grounded in the work ahead to help our customers bring breakthrough medical innovation to more patients.”

AcuityMD combines real-world healthcare data, artificial intelligence-powered insights, and intuitive workflows to provide medtech companies with the information they need to grow market share and accelerate the patient applications of their respective technologies. Its intelligence platform is trusted has been used by many medical technology firms, including Becton Dickinson, Teleflex, and Olympus. AcuityMD also was recently named to Newsweek’s “America’s Greatest Startup Workplaces 2025.” 

Forbes’ “Next Billion-Dollar Startups” list, now in its 11th year, has become a fairly reliable indicator of startup success. Of the list’s 225 alumni, 58% have become unicorns, including DoorDash, Figma, Anduril, Benchling, and Rippling. 

“AcuityMD stands out because the company is applying AI to deliver real ROI in the complex, underserved MedTech market,” said Logan Bartlett, managing director at Redpoint, a venture capital firm focused on investments in seed, early and growth-stage companies. “It’s exactly the kind of business we believe will define the future of AI-powered vertical software.”

The selection process for Forbes’ “Next Billion-Dollar Startups” list is grounded in a data-driven methodology that combines company-submitted information, input from venture capital firms, select third-party data, and historical trends. To qualify, companies must be private, venture-backed, U.S.-based, and have a valuation under $1 billion at the time of consideration. The evaluation model prioritizes key quantitative metrics such as valuation and revenue—which carry the greatest weight—alongside other indicators including user or customer count and employee headcount. Each applicant is assessed within this multi-factor framework to identify startups demonstrating strong growth, scalability, and the potential to surpass the billion-dollar threshold in the near future.

‍AcuityMD developed a medtech Intelligence Platform used by more than 300 medical technology companies including six of the top 10. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and the ways in which to sell faster to accelerate medical technology adoption.

‍